Turning Technology Into Revenue, Trust, and Scale

The constraint may not be product readiness. It may be scenario maturity.

SMAF was not created from theory. It was shaped by Mans International’s decade of hands-on work with technology founders, investors, partners, and cross-border market opportunities across North America, Asia, and global innovation ecosystems.

Scenario Intelligence

Scenario Intelligence is the ability to judge whether a market is ready to adopt, pay for, trust, and scale a technology.

Why do some breakthrough technologies convert to revenue instantly, while others stall in the market?

For our 10th anniversary, Mans International is launching the SMAF Strategic Sprint 2026 to answer exactly that. Using our proprietary Scenario Maturity Assessment Framework (SMAF), this series decodes the journey from raw innovation to market dominance.

The goal is not simply to make the story sound better. The goal is to understand whether the scenario around the technology is strong enough to support growth.

Each case study in the Sprint delivers actionable intelligence across three critical pillars: Market Readiness, Operational Adoption, and Cross-Border Advantage.

Featured cases

As part of SMAF Sprint 2026, Mans International is publishing selected case notes that examine successful, emerging, and difficult technology scenarios through the lens of scenario maturity.

1. Insilico Medicine and the AI-Drug Premium: A SMAF Stress Test
2. SpaceX IPO and the Scenario Premium
3. China’s Embodied AI Playbook: Cost Shock, Narrative Maturity, and the Workflow Test
4. An ALS Breakthrough: A Master Class in Deep-Tech Ecosystem Building, Founder Resilience, and SMAF
5. From Model IQ to Scenario EQ: DeepSeek’s Emotional Data Pivot and AI’s Next Moat
6. AI’s Next 99.5% Opportunity: Why the Winners Will Be Built Beyond SaaS
7. WAIC 2026: When Medical AI Moves Beyond the Model
8. Inside OpenEvidence’s $12B Rise: The Playbook Winning AI Companies Share
9. When AI Levels the Playing Field, What Makes a Winning Founder?
10. The Judgment Trail: Output Is Cheap Now. Judgment Isn’t
11. Compounding Intelligence: What MiniMax’s $116M Revenue Reveals About Real AI Moats

Commercialization challenges & market misalignments

We also analyze complex commercialization challenges and market misalignments, examining cases such as Kintsugi, Medvi, Formation Bio, and LVMH’s WTHN and Cha Ling, Oura’s IPO, Constraint Is the Ultimate Strategy Test to help founders understand why great technology, strong culture, or impressive execution may still fail to convert without scenario maturity.